Cargando…

1-(Prop-2-en-1-yl)-3-{[3-(pyridin-4-yl)-4,5-di­hydro­isoxazol-5-yl]meth­yl}-1H-anthra[1,2-d]imidazole-2,6,11(3H)-trione

The fused five- and three six-membered rings of the anthra[1,2-d]imidazole­trione part of the title compound, C(27)H(20)N(4)O(4), show two different substituents at the imidazole N atoms, viz. an allyl group and a [3-(pyridin-4-yl)-4,5-di­hydro­isoxazol-5-yl]methyl group. The fused-ring system is ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Afrakssou, Zahra, Kandri Rodia, Youssef, Capet, Frédéric, Essassi, El Mokhtar, Rolando, Christian, El Ammari, Lahcen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685089/
https://www.ncbi.nlm.nih.gov/pubmed/23795108
http://dx.doi.org/10.1107/S160053681301369X
_version_ 1782273655180361728
author Afrakssou, Zahra
Kandri Rodia, Youssef
Capet, Frédéric
Essassi, El Mokhtar
Rolando, Christian
El Ammari, Lahcen
author_facet Afrakssou, Zahra
Kandri Rodia, Youssef
Capet, Frédéric
Essassi, El Mokhtar
Rolando, Christian
El Ammari, Lahcen
author_sort Afrakssou, Zahra
collection PubMed
description The fused five- and three six-membered rings of the anthra[1,2-d]imidazole­trione part of the title compound, C(27)H(20)N(4)O(4), show two different substituents at the imidazole N atoms, viz. an allyl group and a [3-(pyridin-4-yl)-4,5-di­hydro­isoxazol-5-yl]methyl group. The fused-ring system is approximately planar [r.m.s. deviation = 0.232 (2) Å], but is slightly buckled along the common edge of the two pairs of adjacent rings, with a dihedral angle between them of 11.17 (6)°. The isoxazole ring makes dihedral angles of 27.2 (2) and 12.7 (2)° with the imidazole and pyridine rings, respectively. Weak C—H⋯O and C—H⋯N hydrogen bonds ensure the cohesion of the crystal structure, forming a three-dimensional network.
format Online
Article
Text
id pubmed-3685089
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-36850892013-06-21 1-(Prop-2-en-1-yl)-3-{[3-(pyridin-4-yl)-4,5-di­hydro­isoxazol-5-yl]meth­yl}-1H-anthra[1,2-d]imidazole-2,6,11(3H)-trione Afrakssou, Zahra Kandri Rodia, Youssef Capet, Frédéric Essassi, El Mokhtar Rolando, Christian El Ammari, Lahcen Acta Crystallogr Sect E Struct Rep Online Organic Papers The fused five- and three six-membered rings of the anthra[1,2-d]imidazole­trione part of the title compound, C(27)H(20)N(4)O(4), show two different substituents at the imidazole N atoms, viz. an allyl group and a [3-(pyridin-4-yl)-4,5-di­hydro­isoxazol-5-yl]methyl group. The fused-ring system is approximately planar [r.m.s. deviation = 0.232 (2) Å], but is slightly buckled along the common edge of the two pairs of adjacent rings, with a dihedral angle between them of 11.17 (6)°. The isoxazole ring makes dihedral angles of 27.2 (2) and 12.7 (2)° with the imidazole and pyridine rings, respectively. Weak C—H⋯O and C—H⋯N hydrogen bonds ensure the cohesion of the crystal structure, forming a three-dimensional network. International Union of Crystallography 2013-05-22 /pmc/articles/PMC3685089/ /pubmed/23795108 http://dx.doi.org/10.1107/S160053681301369X Text en © Afrakssou et al. 2013 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Organic Papers
Afrakssou, Zahra
Kandri Rodia, Youssef
Capet, Frédéric
Essassi, El Mokhtar
Rolando, Christian
El Ammari, Lahcen
1-(Prop-2-en-1-yl)-3-{[3-(pyridin-4-yl)-4,5-di­hydro­isoxazol-5-yl]meth­yl}-1H-anthra[1,2-d]imidazole-2,6,11(3H)-trione
title 1-(Prop-2-en-1-yl)-3-{[3-(pyridin-4-yl)-4,5-di­hydro­isoxazol-5-yl]meth­yl}-1H-anthra[1,2-d]imidazole-2,6,11(3H)-trione
title_full 1-(Prop-2-en-1-yl)-3-{[3-(pyridin-4-yl)-4,5-di­hydro­isoxazol-5-yl]meth­yl}-1H-anthra[1,2-d]imidazole-2,6,11(3H)-trione
title_fullStr 1-(Prop-2-en-1-yl)-3-{[3-(pyridin-4-yl)-4,5-di­hydro­isoxazol-5-yl]meth­yl}-1H-anthra[1,2-d]imidazole-2,6,11(3H)-trione
title_full_unstemmed 1-(Prop-2-en-1-yl)-3-{[3-(pyridin-4-yl)-4,5-di­hydro­isoxazol-5-yl]meth­yl}-1H-anthra[1,2-d]imidazole-2,6,11(3H)-trione
title_short 1-(Prop-2-en-1-yl)-3-{[3-(pyridin-4-yl)-4,5-di­hydro­isoxazol-5-yl]meth­yl}-1H-anthra[1,2-d]imidazole-2,6,11(3H)-trione
title_sort 1-(prop-2-en-1-yl)-3-{[3-(pyridin-4-yl)-4,5-di­hydro­isoxazol-5-yl]meth­yl}-1h-anthra[1,2-d]imidazole-2,6,11(3h)-trione
topic Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685089/
https://www.ncbi.nlm.nih.gov/pubmed/23795108
http://dx.doi.org/10.1107/S160053681301369X
work_keys_str_mv AT afrakssouzahra 1prop2en1yl33pyridin4yl45dihydroisoxazol5ylmethyl1hanthra12dimidazole26113htrione
AT kandrirodiayoussef 1prop2en1yl33pyridin4yl45dihydroisoxazol5ylmethyl1hanthra12dimidazole26113htrione
AT capetfrederic 1prop2en1yl33pyridin4yl45dihydroisoxazol5ylmethyl1hanthra12dimidazole26113htrione
AT essassielmokhtar 1prop2en1yl33pyridin4yl45dihydroisoxazol5ylmethyl1hanthra12dimidazole26113htrione
AT rolandochristian 1prop2en1yl33pyridin4yl45dihydroisoxazol5ylmethyl1hanthra12dimidazole26113htrione
AT elammarilahcen 1prop2en1yl33pyridin4yl45dihydroisoxazol5ylmethyl1hanthra12dimidazole26113htrione